Revenue: 345,523; QoQ growth +3.18%; YoY not disclosed. Gross Profit: 159,869; Gross Margin: 46.27%.
Operating Income: -328,000; Operating Margin: -94.93%. EBITDA: -328,000; EBITDARatio: -0.9493x.
Interest Expense: -18,451; Net Income: -548,000; Net Margin: -158.60%; EPS: -0.105; Weighted Avg Shares Outstanding: 5,219,000.
Liquidity: Cash and cash equivalents 832,368; Total Assets 2,920,066; Total Liabilities 3,171,179; Total Stockholders’ Equity -251,113 (negative).
Leverage: Total Debt 1,957,065; Net Debt 1,124,697; Current Ratio 0.911; Quick Ratio 0.910; Cash Ratio 0.433.
Cash Flow: Net cash provided by operating activities -275,033; Free Cash Flow -277,112; Net cash used in investing activities -103,046; Net cash provided by financing activities 336,649; Net change in cash 11,015; Cash at end of period 832,368; Cash at beginning 821,353.
Asset Turnover 0.118; Receivables Turnover 9.85; Inventory Turnover 98.02; Gross Profit Margin 46.27%; Operating Margin -94.93%; Net Margin -158.60%.
Balance Sheet Highlights: Negative shareholders’ equity (-251,113) and substantial liabilities (Total Liabilities 3,171,179) reflect the SPAC shell structure and the absence of a stand-alone operating business at QQ3 2024. Total Debt to Capitalization and Enterprise Value multiples indicate negative equity influences the calculated ratios (e.g., Enterprise Value Multiple -3.43).